50% off Premium Yearly

NASDAQ:KINS
This summary was created by AI, based on 4 opinions in the last 12 months.
Kingstone Companies Inc (KINS-Q) has recently received a positive outlook from multiple experts, highlighting its strong financial performance and growth potential. The company has reported record earnings with a significant 52% increase in net income and a 14% boost in premiums collected. This has resulted in growing cash reserves and a reduction in debt, signaling financial stability. Experts note a consistent return on equity (ROE) of around 33%-35%, indicating effective management of capital. Analysts have set optimistic price targets ranging from $21 to $22, suggesting a robust upside potential. With a solid business foundation and its addition to the Russell Index, KINS appears to be well-positioned for future growth in the property and casualty insurance sector.
Kingstone Companies Inc is a American stock, trading under the symbol KINS (previously KINS-Q on Stockchase) on the NASDAQ (KINS). It is usually referred to as NASDAQ:KINS or KINS
In the last year, 4 stock analysts issued a Buy, Sell, or Hold rating on KINS (previously KINS-Q on Stockchase). 4 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for Kingstone Companies Inc.
Kingstone Companies Inc was recommended as a Top Pick by The Panic-Proof Portfolio (Stockchase Research) on 2025-07-17. Read the latest stock experts ratings for Kingstone Companies Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Kingstone Companies Inc.
Kingstone Companies Inc is followed by 9 investors on Stockchase and is a trending stock that is worth watching.
On 2026-06-12, Kingstone Companies Inc (KINS) stock closed at a price of $16.23.
Following recently reported record earnings, we reiterate KINS, a regional property and casualty insurance provider in the US Northeast, as a TOP PICK. Low catastrophic liabilities and a 15% increase in premiums collected allowed for growing cash reserves, while debt was reduced. It trades at 8x earnings, 2.1x book and supports a robust 33% ROE. We continue to recommend a stop at $14, looking to achieve $21 -- upside potential of 27%. Yield 0%
(Analysts’ price target is $21.50)